financetom
Business
financetom
/
Business
/
Volkswagen earnings dragged down by EU carbon provision and US tariffs
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Volkswagen earnings dragged down by EU carbon provision and US tariffs
Apr 10, 2025 12:57 AM

BERLIN (Reuters) -Volkswagen's first-quarter earnings fell far short of market expectations, plunging about 40%, as Europe's biggest carmaker factored in costs for penalties of missing EU carbon emissions targets and for cars affected by U.S. tariffs.

Volkswagen's shares were up 8.2%, as relief swept through markets after the U.S. administration's announcement of a 90-day pause on tariffs imposed less than 24 hours earlier on dozens of countries, but a 25% tariff on autos imports remains in place and Volkswagen is heavily exposed.

Europe's autos index was up 4.9% at 0814 GMT, while a wider European index rose 7.9%.

After lobbying from the car sector, the European Commission, the EU executive, has proposed to loosen rules that most of the industry is likely to breach this year, leading to billions of euros in fines.

The proposal, which would give Volkswagen and the rest of the industry more time to boost sales of low emission electric vehicles, has yet to be approved by the European Parliament.

As a result, Volkswagen included a 600 million euro ($658 million) provision for potential fines in its first-quarter result, as well as 200 million euros for restructuring at its software unit Cariad, which is in the midst of layoffs.

That lowers its operating return on sales to around 3.6%, down from 6% last year.

A spokesperson declined to provide detail on the costs related to US tariffs.

Those linked to the valuation of vehicles in transit to the United States, where a 25% import tariff was imposed from April 3, weighed on results.

The bulk of the VW brand's U.S. sales is from cars made in Mexico and its Audi and Porsche brands have no U.S. manufacturing base.

The company confirmed its full-year outlook of up to 5% sales growth and operating return on sales of between 5.5% and 5.6% but said in its results statement these forecasts excluded the possible impact of tariffs since it was too early to assess their impact.

($1 = 0.9113 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Falcon Oil & Gas Completes Shenandoah SS-2H ST1 Stimulation in Australia
Falcon Oil & Gas Completes Shenandoah SS-2H ST1 Stimulation in Australia
Feb 7, 2025
07:07 AM EST, 02/07/2025 (MT Newswires) -- Falcon Oil & Gas ( FOLGF ) on Friday said it has completed the Shenandoah S2-2H ST1 stimulation in the Beetaloo Sub-basin in the Northern Territory, Australia, with joint venture partner Tamboran (B2) Pty. The companies successfully completed 35 stages across the 1,671-meter horizontal section of the Amungee Member B-shale with the Liberty...
Mexican avocado exports steady ahead of Super Bowl despite US tariff tension
Mexican avocado exports steady ahead of Super Bowl despite US tariff tension
Feb 7, 2025
MEXICO CITY (Reuters) - Mexican avocado growers will ship about 110,000 metric tons of the green gold fruit to the United States ahead of Sunday's Super Bowl, as threatened U.S. tariffs that could have derailed exports were paused before taking effect. The Mexican avocado packers and exporters association APEAM said the figure is similar to last year's shipments ahead of...
Guardant Health Agrees to Exchange $600 Million in Convertible Notes, $45 Million Share Buyback
Guardant Health Agrees to Exchange $600 Million in Convertible Notes, $45 Million Share Buyback
Feb 7, 2025
07:06 AM EST, 02/07/2025 (MT Newswires) -- Guardant Health ( GH ) said Friday that it agreed with some creditors a day earlier to exchange $600 million worth of newly issued 1.25% convertible senior notes due 2031 for $659.3 million worth of outstanding 0% Convertible Senior Notes due 2027. The initial conversion rate of the new notes will be 16.0716...
Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation
Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation
Feb 7, 2025
07:07 AM EST, 02/07/2025 (MT Newswires) -- Eton Pharmaceuticals ( ETON ) said Friday that the US Patent and Trademark Office has granted a patent for the formulation of its ET-600 product candidate, a desmopressin oral solution being developed as potential treatment for diabetes insipidus. The company said the patent expires in 2044 and is expected to be listed in...
Copyright 2023-2025 - www.financetom.com All Rights Reserved